Cargando…

Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis

Cystic fibrosis (CF) is an important monogenic disease that affects more than 70 000 people worldwide. Defects of the CF transmembrane conductance regulator gene lead to dehydrated viscous secretions that result in chronic bacterial colonization. This leads to frequent recurrent lung infections call...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hahn, Andrea, Sami, Iman, Chaney, Hollis, Koumbourlis, Anastassios C., Del Valle Mojica, Coralee, Cochrane, Claire, Chan, Benjamin K., Koff, Jonathan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387758/ https://www.ncbi.nlm.nih.gov/pubmed/37515541 http://dx.doi.org/10.1177/23247096231188243

Ejemplares similares

Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids
por: Felton, Erin, et al.
Publicado: (2021)

2573. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Lung Microbiome Diversity and Pulmonary Function
por: Jason. Bozzella, Michael, et al.
Publicado: (2019)

Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2023)

Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity
por: Hahn, Andrea, et al.
Publicado: (2018)

Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2021)

Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis
por: Shumyatsky, Gabriella, et al.
Publicado: (2023)

Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation
por: Inam, Zaina, et al.
Publicado: (2022)

Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity
por: Hahn, Andrea, et al.
Publicado: (2018)

Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis
por: Kennedy, Charles, et al.
Publicado: (2022)

Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation
por: Hahn, Andrea, et al.
Publicado: (2020)

The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages
por: Essoh, Christiane, et al.
Publicado: (2013)

Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status
por: Hraiech, Sami, et al.
Publicado: (2015)

Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2019)

Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study
por: Hahn, Andrea, et al.
Publicado: (2020)

Modular Approach to Select Bacteriophages Targeting Pseudomonas aeruginosa for Their Application to Children Suffering With Cystic Fibrosis
por: Krylov, Victor, et al.
Publicado: (2016)

Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention
por: Morello, Eric, et al.
Publicado: (2011)

Temperate Bacteriophages (Prophages) in Pseudomonas aeruginosa Isolates Belonging to the International Cystic Fibrosis Clone (CC274)
por: Ambroa, Antón, et al.
Publicado: (2020)

Analysis of Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis Revealed Novel Groups of Filamentous Bacteriophages
por: Evseev, Peter, et al.
Publicado: (2023)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
por: Cramer, Nina, et al.
Publicado: (2014)

In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
por: Olszak, Tomasz, et al.
Publicado: (2015)

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
por: Sordé, Roger, et al.
Publicado: (2011)

Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
por: Bhagirath, Anjali Y., et al.
Publicado: (2016)

Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis
por: Rada, Balázs
Publicado: (2017)

Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Keown, Karen, et al.
Publicado: (2020)

Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review
por: Rossitto, Martina, et al.
Publicado: (2018)

Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and Pseudomonas aeruginosa
por: Singh, Jagdev, et al.
Publicado: (2023)

Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review
por: Chegini, Zahra, et al.
Publicado: (2020)

Variability in Bacteriophage and Antibiotic Sensitivity in Serial Pseudomonas aeruginosa Isolates from Cystic Fibrosis Airway Cultures over 12 Months
por: Martin, Isaac, et al.
Publicado: (2021)

Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis
por: Knibbs, Luke D, et al.
Publicado: (2014)

Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Høiby, Niels
Publicado: (2011)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Hurley, Matthew N., et al.
Publicado: (2012)

The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients
por: van Mansfeld, Rosa, et al.
Publicado: (2016)

Adherence of Pseudomonas aeruginosa to cystic fibrosis buccal epithelial cells
por: Lingner, Meike, et al.
Publicado: (2017)

Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Zhao, Jingming, et al.
Publicado: (2018)

Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Pseudomonas aeruginosa Infection
por: Martin, Isaac, et al.
Publicado: (2023)

Inhalation with Fucose and Galactose for Treatment of Pseudomonas Aeruginosa in Cystic Fibrosis Patients
por: Hauber, Hans-Peter, et al.
Publicado: (2008)

Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
por: Pukhalsky, A L, et al.
Publicado: (1999)

Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice
por: Wang, Yufa, et al.
Publicado: (2010)

Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient
por: Workentine, Matthew L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_adl18fqqps7mv7aiops92pbroc